Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Calponin 2 regulates ketogenesis to mitigate acute kidney injury
Yuan Gui, Zachary Palanza, Priya Gupta, Hanwen Li, Yuchen Pan, Yuanyuan Wang, Geneva Hargis, Donald L. Kreutzer, Yanlin Wang, Sheldon I. Bastacky, Yansheng Liu, Silvia Liu, Dong Zhou
Yuan Gui, Zachary Palanza, Priya Gupta, Hanwen Li, Yuchen Pan, Yuanyuan Wang, Geneva Hargis, Donald L. Kreutzer, Yanlin Wang, Sheldon I. Bastacky, Yansheng Liu, Silvia Liu, Dong Zhou
View: Text | PDF
Research Article Nephrology

Calponin 2 regulates ketogenesis to mitigate acute kidney injury

  • Text
  • PDF
Abstract

Calponin 2 (CNN2) is a prominent actin stabilizer. It regulates fatty acid oxidation (FAO) by interacting with estrogen receptor 2 (ESR2) to determine kidney fibrosis. However, whether CNN2 is actively involved in acute kidney injury (AKI) remains unclear. Here, we report that CNN2 was induced in human and animal kidneys after AKI. Knockdown of CNN2 preserved kidney function, mitigated tubular cell death and inflammation, and promoted cell proliferation. Distinct from kidney fibrosis, proteomics showed that the key elements in the FAO pathway had few changes during AKI, but we identified that 3-hydroxymethylglutaryl-CoA synthase 2 (Hmgcs2), a rate-limiting enzyme of endogenous ketogenesis that promotes cell self-renewal, was markedly increased in CNN2-knockdown kidneys. The production of ketone body β-hydroxybutyrate and ATP was increased in CNN2-knockdown mice. Mechanistically, CNN2 interacted with ESR2 to negatively regulate the activities of mitochondrial sirtuin 5. Activated sirtuin 5 subsequently desuccinylated Hmgcs2 to produce energy for mitigating AKI. Understanding CNN2-mediated discrete fine-tuning of protein posttranslational modification is critical to optimize organ performance after AKI.

Authors

Yuan Gui, Zachary Palanza, Priya Gupta, Hanwen Li, Yuchen Pan, Yuanyuan Wang, Geneva Hargis, Donald L. Kreutzer, Yanlin Wang, Sheldon I. Bastacky, Yansheng Liu, Silvia Liu, Dong Zhou

×

Figure 8

CNN2 inhibits Hmgcs2 desuccinylation to accelerate tubular cell death in vitro.

Options: View larger image (or click on image) Download as PowerPoint
CNN2 inhibits Hmgcs2 desuccinylation to accelerate tubular cell death in...
(A) Representative Western blots showed that human CNN2 recombinant protein markedly repressed sirt5 and Hmgcs2 expression in NRK-52E cells at different dosages under hypoxic stress. (B) Western blot assay demonstrated CNN2 recombinant protein enhanced the abundance of Succ-K in NRK-52E cells at different dosages under hypoxia stress, compared with controls. (C) Co-immunoprecipitation revealed that lysine succinylation on Hmgcs2 is increased after human CNN2 recombinant protein treatment under hypoxia stress. (D) Western blot assay showed that human CNN2 recombinant protein induced Bax and NGAL expression at different dosages under hypoxic stress, compared with vehicle. (E–G) After stimulation with staurosporine (1 μM) for 3 hours, immunofluorescence staining showed increased CCP3+ tubular cells after being incubated with human CNN2 recombinant protein (E) and quantitative data are presented (F). Scale bar, 25 μm. *P < 0.05 (n = 3). Western blots demonstrated the upregulated abundance of CCP3 in cultured NRK-52E cells after incubation with CNN2 recombinant protein (G). (H) Western blot assay showed β-OHB decreased the abundance of CCP3 after being treated with CNN2 recombinant protein in cultured NRK-52E cells. (I) Schematic diagram depicts knockdown of CNN2 enhanced ketogenesis to mitigate AKI. Graphs are presented as means ± SEM. Differences between groups were analyzed using ANOVA followed by the Student-Newman-Keuls test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts